Difficulty: Medium
Average Score: 69%
Practice
Recommended combination therapy for uncomplicated anorectal and pharyngeal gonorrhea is?
Correct answer
D
Rationale
In the context of pharmacology and the treatment of anorectal and pharyngeal gonorrhea, the recommended combination therapy of ceftriaxone and azithromycin (Option D) is based on current guidelines from the Centers for Disease Control and Prevention (CDC). Ceftriaxone is the preferred treatment for gonorrhea due to increasing antibiotic resistance, and azithromycin is typically added to provide dual coverage and to combat potential co-infection with Chlamydia trachomatis.
Option A, ceftriaxone and benzathine penicillin, is incorrect because penicillin is no longer recommended as monotherapy for gonorrhea due to high rates of resistance. Option B, benzathine penicillin and doxycycline, is also incorrect as doxycycline is not the preferred agent for treating uncomplicated gonorrhea. Option C, doxycycline and ciprofloxacin, is not recommended due to high rates of resistance to ciprofloxacin in gonorrhea strains.
This question highlights the importance of staying current with treatment guidelines and understanding the rationale behind combination therapies for infectious diseases to ensure effective management and prevent the development of antibiotic resistance. It also emphasizes the need for healthcare providers to be aware of evolving treatment protocols and to adapt their practice accordingly to provide optimal care for patients with sexually transmitted infections.
Option A, ceftriaxone and benzathine penicillin, is incorrect because penicillin is no longer recommended as monotherapy for gonorrhea due to high rates of resistance. Option B, benzathine penicillin and doxycycline, is also incorrect as doxycycline is not the preferred agent for treating uncomplicated gonorrhea. Option C, doxycycline and ciprofloxacin, is not recommended due to high rates of resistance to ciprofloxacin in gonorrhea strains.
This question highlights the importance of staying current with treatment guidelines and understanding the rationale behind combination therapies for infectious diseases to ensure effective management and prevent the development of antibiotic resistance. It also emphasizes the need for healthcare providers to be aware of evolving treatment protocols and to adapt their practice accordingly to provide optimal care for patients with sexually transmitted infections.